Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      Circulating extracellular vesicles (EVs) regulate signaling pathways via receptor-ligand interactions and content delivery, after attachment or internalization by endothelial cells. However, they originate from diverse cell populations and are heterogeneous in composition. To determine the effects of specific surface molecules, the use of synthetic EV mimetics permits the study of specific EV receptor-ligand interactions. Here, we used endogenous EVs derived from the circulation of rats, as well as ligand-decorated synthetic microparticles (MPs) to examine the role of integrin αvβ3 in platelet adhesion under flow in structurally intact cerebral arteries. At an intraluminal pressure of 50 mmHg and flow rate of 10 µl/min, platelets were delivered to the artery lumen and imaged with whole-field fluorescent microscopy. Under basal conditions very few platelets bound to the endothelium. However, adhesion events were markedly increased following the introduction of arginine-glycine-aspartate (RGD)-labelled synthetic MPs or endogenously-derived EVs from experimental stroke animals carrying excess RGD proteins, including vitronectin, CD40-ligand and thrombospondin-1. These data, which were generated in a dynamic and physiologically relevant system, demonstrate the importance of vesicle-carried RGD ligands in platelet adherence to the cerebrovascular endothelium and highlight the ability of synthetic EVs to isolate and identify key components of the molecular handshake between EVs and their targets.
    • References:
      J Cell Biol. 1992 Jun;117(5):1109-17. (PMID: 1374416)
      Stroke. 2017 Aug;48(8):2292-2296. (PMID: 28536169)
      Oncotarget. 2017 Apr 11;8(15):25700-25712. (PMID: 28147325)
      Biol Reprod. 2013 Dec 26;89(6):151. (PMID: 24227753)
      J Cell Biol. 2002 Dec 23;159(6):1071-86. (PMID: 12486108)
      Angiogenesis. 2009;12(1):17-24. (PMID: 19067197)
      Atherosclerosis. 2011 Dec;219(2):579-87. (PMID: 21872249)
      Nat Med. 2002 Oct;8(10):1175-81. (PMID: 12244306)
      Shock. 2016 Jan;45(1):82-7. (PMID: 26529651)
      FEBS Lett. 1990 Jul 2;267(1):43-5. (PMID: 2365089)
      J Clin Invest. 1991 Oct;88(4):1128-34. (PMID: 1918367)
      Nat Med. 2007 Oct;13(10):1253-8. (PMID: 17891147)
      J Immunol Methods. 2012 Jan 31;375(1-2):207-14. (PMID: 22075275)
      Cell Tissue Res. 2003 Oct;314(1):131-44. (PMID: 13680353)
      Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2306-15. (PMID: 17220190)
      Nano Lett. 2008 Sep;8(9):2599-606. (PMID: 18386933)
      Nat Commun. 2017 Feb 15;8:14254. (PMID: 28198362)
      Biomaterials. 2002 Jan;23(2):585-96. (PMID: 11761179)
      J Thromb Haemost. 2006 Jun;4(6):1296-302. (PMID: 16706974)
      Thromb Haemost. 2009 Dec;102(6):1093-102. (PMID: 19967139)
      Science. 2002 Apr 5;296(5565):151-5. (PMID: 11884718)
      Circulation. 1997 Sep 16;96(6):1809-18. (PMID: 9323066)
      Front Biosci. 2004 May 01;9:1339-47. (PMID: 14977549)
      J Cell Biol. 1988 Jun;106(6):2171-82. (PMID: 2454933)
      FEBS Lett. 1991 Oct 7;291(1):50-4. (PMID: 1718779)
      Circulation. 2002 Nov 5;106(19):2442-7. (PMID: 12417540)
      J Clin Invest. 2008 Mar;118(3):1198-207. (PMID: 18274670)
      Microcirculation. 2007 Sep-Oct;14(7):667-81. (PMID: 17885993)
      Invest Radiol. 2011 Apr;46(4):215-24. (PMID: 21343825)
    • Grant Information:
      16945 United Kingdom CRUK_ Cancer Research UK; RF1 AG065406 United States AG NIA NIH HHS; R01 AG054651 United States AG NIA NIH HHS; United Kingdom BHF_ British Heart Foundation
    • الرقم المعرف:
      0 (Integrin alphaVbeta3)
    • الموضوع:
      Date Created: 20191103 Date Completed: 20201027 Latest Revision: 20240312
    • الموضوع:
      20240312
    • الرقم المعرف:
      PMC6825169
    • الرقم المعرف:
      10.1038/s41598-019-52127-3
    • الرقم المعرف:
      31676801